Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ·Healthcare·Biotechnology
$693.15
+3.89%
Mkt Cap $67.58B
Analyst Ratings
Buy
23
Hold
7
Sell
0
Price Target (130 analysts)
$836.00
Range $641.00 – $995.00
Implied Upside
+20.6%
Consensus $836.00 vs current $693.15